The Trump administration plans to claw again $7.8 billion in Medicare funds to hospitals a decade prior to initially proposed, doubtlessly sparking one other authorized problem from the hospital trade.
President Trump’s Medicare company additionally intends to ship surveys to hospitals asking what their drug prices are, which may set the stage for the Trump administration to aim to chop hospital drug funds once more.
Each proposals relate to the federal 340B drug program, during which hospitals are in a position to buy prescribed drugs at steep reductions with the intent of constructing medicines extra inexpensive for low-income sufferers. Medicare pays hospitals for these medication at a lot larger charges, and critics say hospitals have abused the $66 billion program consequently.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
